EUVIMEDEUVIMED entdecken
Crossref

A peptidic network antibody inhibits both angiogenesis and inflammatory response

Hui Zhang, Kuo Zhang, Qing-Shi Zhang, Lei Wang, Yong-Hong Gao, Guo-Yang Xu, Da Long, Hao Wang, Ying Hu

Journal of Controlled Release · 2023

DOI: 10.1016/j.jconrel.2023.09.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2023. Verfasst von Hui Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Peptides, Corneal Neovascularization. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Sciences, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Corneal neovascularization (CNV) is a global threat to human health. Traditional anti-angiogenesis agent may have therapy effect, while the inflammation in disease area remains unsolved. Herein, we reported two binding-induced fibrillogenesis (BIF) peptides as peptidic network antibodies for high-efficient and long-lasting anti-angiogenesis with reduced inflammatory response. BIF peptides could self-assemble into nanoparticles and further perform BIF behavior through binding Ca2+. In vitro, the migration of integrin αvβ3 highly expressed endothelial cells was inhibited by BIF peptides. In vivo, one BIF peptide (0.012 mg/Kg) exhibited higher anti-angiogenesis effect than monoclonal antibody bevacizumab (0.96 mg/Kg) in a CNV rabbit model on day 14, despite that the dose of BIF was only 1.3% of bevacizumab. Meanwhile, the inflammatory response, such as PI3 kinase/Akt pathway in CNV was successfully inhibited as well. The peptidic network antibody could block integrin αvβ3 via a long-term retention mode, which led to long-term therapeutic effect. The study provides BIF peptides as promising therapeutic agents for both anti-angiogenesis and reduced inflammatory response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiogenesis InhibitorsPeptidesCorneal NeovascularizationAnimalsRabbitsIntegrin alphaVbeta3HumansInflammationHuman Umbilical Vein Endothelial CellsMaleCell MovementBevacizumabNanoparticlesAngiogenesis

Stichwörter der Autor:innen

Anti-angiogenesisBinding-induced fibrillogenesisCorneal neovascularizationInflammationPeptide

Substanzen

Integrin alphaVbeta3Angiogenesis InhibitorsPeptidesBevacizumab

Autor:innen und Institutionen

  • Department of Ophthalmology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.
  • CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), No. 11 Beiyitiao, Zhongguancun, Beijing 100190…
  • Department of Ophthalmology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600, Yishan Road, Shanghai 200233, China. Electronic address: 7250013210@shsmu.edu.cn.
  • Department of Ophthalmology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600, Yishan Road, Shanghai 200233, China. Electronic address: 13046@6hospital.com.

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Sciences
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, H., Zhang, K., Zhang, Q. S., Wang, L., Gao, Y. H., Xu, G. Y., Long, D., Wang, H., & Hu, Y. (2023). A peptidic network antibody inhibits both angiogenesis and inflammatory response. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2023.09.019

Vancouver

Zhang H, Zhang K, Zhang QS, Wang L, Gao YH, Xu GY, et al. A peptidic network antibody inhibits both angiogenesis and inflammatory response. Journal of Controlled Release. 2023. doi:10.1016/j.jconrel.2023.09.019

BibTeX
@article{Zhang2023,
  author = {Zhang, Hui and Zhang, Kuo and Zhang, Qing-Shi and Wang, Lei and Gao, Yong-Hong and Xu, Guo-Yang and Long, Da and Wang, Hao and Hu, Ying},
  title = {A peptidic network antibody inhibits both angiogenesis and inflammatory response},
  journal = {Journal of Controlled Release},
  year = {2023},
  doi = {10.1016/j.jconrel.2023.09.019}
}
Kostenlos starten →